Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

31.33USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$31.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
276,993
52-wk High
$41.75
52-wk Low
$15.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
FY 2016 Dec '16 0.00 -0.551
Sep '16 0.00 -0.526
Jun '16 0.00 -0.434
Mar '16 0.00 -0.372
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 7 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 7 0.00 0.00 0.00 0.00
Year Ending Dec-18 7 0.00 0.00 0.00 15.10
Year Ending Dec-19 8 41.33 142.01 0.00 40.65
Earnings (per share)
Quarter Ending Jun-18 7 -0.73 -0.60 -0.89 -0.78
Quarter Ending Sep-18 7 -0.77 -0.60 -0.96 -0.87
Year Ending Dec-18 8 -2.94 -2.33 -3.69 -3.23
Year Ending Dec-19 6 -2.52 -1.57 -3.62 -2.25
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta -- 0.89 0.88
Price to Sales (TTM) -- 3.94 5.71
Price to Book (MRQ) 5.40 4.80 5.37
Price to Tangible Book (MRQ) 5.41 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 85.47 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 4.83 5.69
Sales - 5 Yr. Growth Rate -- 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate -- 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 13.45 2.90 2.98
LT Debt to Equity (MRQ) 0.00 9.88 12.18
Total Debt to Equity (MRQ) 0.00 13.86 16.45
Interest Coverage (TTM) -- 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.44
Gross Margin - 5 Yr. Avg. -- 52.15 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.57 10.96
Operating Margin (TTM) -- 14.36 4.73
Operating Margin - 5 Yr. Avg. -- 14.52 6.40
Pre-Tax Margin (TTM) -- 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.90 6.81
Net Profit Margin (TTM) -- 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -- 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 938,080,053 846,831,062
Net Income/Employee (TTM) -1,529,406 110,368,379 99,616,205
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 0.00 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 11.40 10.95
Return on Assets - 5 Yr. Avg. -- 12.91 12.31
Return on Investment (TTM) -50.47 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.10
Return on Equity (TTM) -50.82 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 99 23
13 Week 22.10 16.15 99 34
26 Week 26.67 17.04 99 29
52 Week 53.60 30.19 99 12
YTD 24.01 8.91 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.03%
# of Holders: 185
Total Shares Held: 42,957,680
3 Mo. Net Change: 792,479
# New Positions: 7
# Closed Positions: 2
# Increased Positions: 14
# Reduced Positions: 9
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.